JP2023512151A5 - - Google Patents
Info
- Publication number
- JP2023512151A5 JP2023512151A5 JP2022539749A JP2022539749A JP2023512151A5 JP 2023512151 A5 JP2023512151 A5 JP 2023512151A5 JP 2022539749 A JP2022539749 A JP 2022539749A JP 2022539749 A JP2022539749 A JP 2022539749A JP 2023512151 A5 JP2023512151 A5 JP 2023512151A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- composition according
- igsf8
- cancer
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2019/128294 | 2019-12-25 | ||
| CN2019128294 | 2019-12-25 | ||
| PCT/CN2020/139033 WO2021129744A1 (en) | 2019-12-25 | 2020-12-24 | Compositions and methods for treating autoimmune diseases and cancers by targeting igsf8 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023512151A JP2023512151A (ja) | 2023-03-24 |
| JP2023512151A5 true JP2023512151A5 (https=) | 2023-12-21 |
Family
ID=76575703
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022539749A Pending JP2023512151A (ja) | 2019-12-25 | 2020-12-24 | Ｉｇｓｆ８を標的化することによる自己免疫疾患および癌を治療するための組成物および方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230056288A1 (https=) |
| EP (1) | EP4081253A4 (https=) |
| JP (1) | JP2023512151A (https=) |
| KR (1) | KR20220151161A (https=) |
| CN (1) | CN115551549A (https=) |
| AU (1) | AU2020413633A1 (https=) |
| CA (1) | CA3165908A1 (https=) |
| IL (1) | IL294280A (https=) |
| MX (1) | MX2022008061A (https=) |
| TW (1) | TW202135861A (https=) |
| WO (1) | WO2021129744A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116724051A (zh) * | 2020-08-10 | 2023-09-08 | 上海寻百会生物技术有限公司 | 用于通过靶向igsf8来治疗自身免疫性疾病和癌症的组合物和方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2604844A1 (en) * | 2005-04-07 | 2006-10-19 | Novartis Vaccines And Diagnostics, Inc. | Cancer-related genes |
| WO2008034076A2 (en) * | 2006-09-15 | 2008-03-20 | The Johns Hopkins University | Cyclophosphamide in combination with immune therapeutics |
| WO2012021840A2 (en) * | 2010-08-13 | 2012-02-16 | Biovest International, Inc. | Materials and methods for designing autologous idiotype vaccines and treatment of b-cell malignancies |
| EP2824112B1 (en) * | 2013-07-10 | 2016-12-21 | Miltenyi Biotec GmbH | Method for inducing proliferation of Natural Killer cells by mobile nanomatrices |
| EP3688011A4 (en) * | 2017-10-25 | 2021-11-24 | The Administrators Of The Tulane Educational Fund | PEPTIDE COMPOSITIONS AND METHOD FOR THEIR USE |
| US12545728B2 (en) * | 2019-02-04 | 2026-02-10 | Lonza Sales Ag | Treatment of cancer metastasis by targeting exosome proteins |
-
2020
- 2020-12-24 KR KR1020227025743A patent/KR20220151161A/ko active Pending
- 2020-12-24 MX MX2022008061A patent/MX2022008061A/es unknown
- 2020-12-24 AU AU2020413633A patent/AU2020413633A1/en active Pending
- 2020-12-24 WO PCT/CN2020/139033 patent/WO2021129744A1/en not_active Ceased
- 2020-12-24 CN CN202080097544.8A patent/CN115551549A/zh active Pending
- 2020-12-24 EP EP20905174.7A patent/EP4081253A4/en active Pending
- 2020-12-24 TW TW109146016A patent/TW202135861A/zh unknown
- 2020-12-24 US US17/789,079 patent/US20230056288A1/en active Pending
- 2020-12-24 CA CA3165908A patent/CA3165908A1/en active Pending
- 2020-12-24 JP JP2022539749A patent/JP2023512151A/ja active Pending
- 2020-12-24 IL IL294280A patent/IL294280A/en unknown